ISSN 2149-2263 | E-ISSN 2149-2271
The Anatolian Journal of Cardiology
The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARIN-TR [Anatol J Cardiol]
Anatol J Cardiol. 2016; 16(8): 595-600 | DOI: 10.5152/AnatolJCardiol.2015.6474

The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARIN-TR

Ahmet Çelik1, Servet İzci2, Mehmet Ali Kobat3, Ahmet Hakan Ateş4, Abdülkadir Çakmak5, Yasin Çakıllı6, Mehmet Birhan Yılmaz7, Mehdi Zoghi8
1Department of Cardiology, Faculty of Medicine, Mersin University, Mersin- Turkey
2Department of Cardiology, Koşuyolu Education and Research Hospital, İstanbul- Turkey
3Department of Cardiology, Faculty of Medicine, Fırat University, Elazığ- Turkey
4Department of Cardiology, Samsun Education and Research Hospital, Samsun- Turkey
5Department of Cardiology, Faculty of Medicine, Amasya University, Amasya- Turkey
6Department of Cardiology, Siyami Ersek Education and Research Hospital, İstanbul- Turkey
7Department of Cardiology, Faculty of Medicine, Cumhuriyet University, Sivas- Turkey
8Department of Cardiology, Faculty of Medicine, Ege University, İzmir- Turkey

Objective: The awareness, time in therapeutic range (TTR), and safety of warfarin therapy were investigated in the adult Turkish population.
Methods: This multicenter prospective study includes 4987 patients using warfarin and involved regular international normalized ratio (INR) monitoring between January 1, 2014 and December 31, 2014. TTR was calculated according to F.R. Roosendaal’s algorithm. Awareness was evaluated based on the patients’ knowledge of warfarin’s affect and food–drug interactions.
Results: The mean TTR of patients was 49.52±22.93%. The patients with hypertension (55.3%), coronary artery disease (23.2%), congestive heart failure (24.5%), or smoking habit (20.8%) had significantly lower TTR levels than the others. Of the total number of patients, 42.6% had a mechanical valve, 38.4% had non-valvular atrial fibrillation (AF), and 19% had other indications for warfarin. Patients with other indications had lower TTR levels than those with mechanical valve and non-valvular AF (p=0.018). Warfarin awareness decreased in higher age groups. The knowledge of warfarin’s food–drug interactions was 55%. People with higher warfarin awareness had higher TTR levels. Patients with ≤8 INR monitoring/year had lower TTR levels (46.4±25.3 vs. 51.1±21.3, respectively, p<0.001) and lower awareness (44.6% vs. 60.6%, p<0.001) than patients with ≥8 INR monitoring/year. In this study, 20.1% of the patients had a bleeding event (major bleeding 15.8%, minor bleeding 84.2%) within a year.
Conclusion: Both the mean TTR ratios and awareness of the Turkish population on warfarin therapy were found to be low. It was thought that low TTR levels of the Turkish population may be caused by the low awareness of warfarin, warfarin’s food–drug interactions, and high rates of concomitant diseases. (Anatol J Cardiol 2016; 16: 000-00)

Keywords: time in therapeutic range, warfarin, Turkish population

Ahmet Çelik, Servet İzci, Mehmet Ali Kobat, Ahmet Hakan Ateş, Abdülkadir Çakmak, Yasin Çakıllı, Mehmet Birhan Yılmaz, Mehdi Zoghi. The awareness, efficacy, safety, and time in therapeutic range of warfarin in the Turkish population: WARFARIN-TR. Anatol J Cardiol. 2016; 16(8): 595-600

Corresponding Author: Ahmet Çelik, Türkiye
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.